Craig Hallum Begins Coverage on SOPHiA GENETICS (NASDAQ:SOPH)

Craig Hallum began coverage on shares of SOPHiA GENETICS (NASDAQ:SOPH) in a research note published on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $11.00 price objective on the stock.

SOPHiA GENETICS Stock Performance

SOPH stock opened at $3.26 on Wednesday. SOPHiA GENETICS has a 1 year low of $2.70 and a 1 year high of $7.37. The stock has a market capitalization of $213.12 million, a price-to-earnings ratio of -2.99 and a beta of 0.99. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.59 and a current ratio of 3.80. The stock’s fifty day moving average is $3.42 and its two-hundred day moving average is $3.90.

SOPHiA GENETICS (NASDAQ:SOPH) last posted its earnings results on Tuesday, November 5th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.04). SOPHiA GENETICS had a negative net margin of 110.71% and a negative return on equity of 55.06%. The firm had revenue of $15.85 million for the quarter, compared to analyst estimates of $15.90 million. During the same period in the previous year, the firm earned ($0.21) earnings per share. On average, research analysts predict that SOPHiA GENETICS will post -0.98 EPS for the current year.

Institutional Trading of SOPHiA GENETICS

Several hedge funds have recently added to or reduced their stakes in the business. Banque Cantonale Vaudoise increased its holdings in shares of SOPHiA GENETICS by 300.0% during the second quarter. Banque Cantonale Vaudoise now owns 12,000 shares of the company’s stock valued at $55,000 after purchasing an additional 9,000 shares during the period. Green Alpha Advisors LLC bought a new stake in shares of SOPHiA GENETICS during the 3rd quarter worth about $79,000. Federated Hermes Inc. lifted its stake in shares of SOPHiA GENETICS by 57.5% in the 2nd quarter. Federated Hermes Inc. now owns 63,000 shares of the company’s stock worth $289,000 after acquiring an additional 23,000 shares during the period. Finally, Principal Financial Group Inc. boosted its holdings in shares of SOPHiA GENETICS by 6.3% in the third quarter. Principal Financial Group Inc. now owns 1,455,142 shares of the company’s stock valued at $5,290,000 after acquiring an additional 86,764 shares in the last quarter. Institutional investors own 31.59% of the company’s stock.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.